IntercontinentalExchange in a wide range of matters, including ongoing development of its ICE Clear Credit, ICE Clear Europe and ICE Clear US clearinghouses for credit default swaps and other products, resolution and recovery planning for clearinghouses, development of segregation models, client clearing solutions and bankruptcy remote structures, new product and rulebook development, U.S. and EU regulatory “equivalence” and other cross-border regulatory issues, and SEC and CFTC regulatory matters.

CVS Health in its $10.6 billion acquisition of Oak Street Health.

A non-U.S. financial institution in development of a program for financing of trade receivables through participations, derivatives and structured notes.

U.S. and non-U.S. financial institutions in structured sovereign repo transactions and related hedging activities.

A U.S. financial institution in the synthetic securitization of housing loans.

U.S. and non-U.S. corporate issuers in connection with equity derivative transactions, including monetization and financing transactions and stock buyback transactions.

U.S. and non-U.S. financial institutions in connection with U.S. regulatory reform affecting derivatives and structured products, including compliance with Dodd-Frank Act requirements.

U.S. and non-U.S. financial institutions in connection with derivatives transaction close-out and counterparty risk management for derivatives transactions, including in connection with insolvency and resolution matters.

FX trading platform in connection with the implementation of CFTC retail foreign exchange dealer requirements.

Depository Trust & Clearing Corporation in connection with the development of its derivatives processing services and infrastructure, including development of its Trade Information Warehouse.